Kontafarma China Holdings Ltd (1312) Financial Statements

0 Followers

Kontafarma China Holdings Ltd Financial Overview

Kontafarma China Holdings Ltd's market cap is currently HK$167.36M. The company's EPS TTM is HK$-0.0761; its P/E ratio is -0.38; Kontafarma China Holdings Ltd is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 914.71M	HK$ 897.52M	HK$ 809.11M	HK$ 894.06M	HK$ 803.27M
Gross Profit	HK$ 513.64M	HK$ 516.16M	HK$ 471.29M	HK$ 506.22M	HK$ 396.18M
Operating Income	HK$ -44.90M	HK$ -42.51M	HK$ -164.30M	HK$ -137.29M	HK$ -97.71M
EBITDA	HK$ -14.32M	HK$ -49.93M	HK$ 78.50M	HK$ 26.93M	HK$ 112.18M
Net Income	HK$ -427.85M	HK$ -75.54M	HK$ -28.84M	HK$ -41.55M	HK$ -15.05M
Balance Sheet
Cash & Short-Term Investments	HK$ 66.06M	HK$ 90.58M	HK$ 87.66M	HK$ 142.59M	HK$ 183.96M
Total Assets	HK$ 1.07B	HK$ 1.59B	HK$ 1.73B	HK$ 2.12B	HK$ 2.56B
Total Debt	HK$ 203.68M	HK$ 297.19M	HK$ 333.82M	HK$ 590.72M	HK$ 728.95M
Net Debt	HK$ 137.62M	HK$ 216.60M	HK$ 256.16M	HK$ 468.13M	HK$ 560.99M
Total Liabilities	HK$ 588.92M	HK$ 625.90M	HK$ 665.39M	HK$ 964.16M	HK$ 1.22B
Stockholders' Equity	HK$ 553.26M	HK$ 978.70M	HK$ 1.06B	HK$ 1.10B	HK$ 1.19B
Cash Flow
Free Cash Flow	HK$ 53.15M	HK$ 33.41M	HK$ 12.92M	HK$ -53.84M	HK$ -49.31M
Operating Cash Flow	HK$ 76.68M	HK$ 47.05M	HK$ 37.12M	HK$ -2.17M	HK$ 75.07M
Investing Cash Flow	HK$ 8.82M	HK$ -6.01M	HK$ 144.14M	HK$ 121.53M	HK$ 23.24M
Financing Cash Flow	HK$ -90.16M	HK$ -42.52M	HK$ -198.81M	HK$ -137.33M	HK$ -99.80M

Currency in HKD

Kontafarma China Holdings Ltd Earnings and Revenue History

Income Statement >

Kontafarma China Holdings Ltd Debt to Assets

Balance Sheet >

Kontafarma China Holdings Ltd Cash Flow

Cash Flow >

Kontafarma China Holdings Ltd Forecast EPS vs Actual EPS

Earnings >